Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | SH3BGRL3 |
| Upstream (Parents) |
|---|
| (<<) S100A11 → SH3BGRL3 |
| (<<) PLAUR → SH3BGRL3 |
| (<<) SLC25A15 → SH3BGRL3 |
| (<<) CBR4 → SH3BGRL3 |
| Downstream (Children) |
|---|
| SH3BGRL3 → TREM2 (>>) |
| SH3BGRL3 → FGF3 (>>) |
| SH3BGRL3 → ISG20 (>>) |
| SH3BGRL3 → TTTY2B///TTTY2 (>>) |
| SH3BGRL3 → MINK1 (>>) |
| SH3BGRL3 → TREM1 (>>) |
| SH3BGRL3 → UNC93B1 (>>) |
| SH3BGRL3 → CREB3L1 (>>) |
| SH3BGRL3 → PROX1 (>>) |
| SH3BGRL3 → IL18 (>>) |
| SH3BGRL3 → PLK3 (>>) |
| SH3BGRL3 → LOC730101 (>>) |
| SH3BGRL3 → KHDRBS1 (>>) |
| SH3BGRL3 → ATP13A2 (>>) |
| SH3BGRL3 → UPP1 (>>) |
